当前位置:首页 - 行情中心 - 药明康德(603259) - 财务分析 - 利润表

药明康德

(603259)

71.91

-3.47  (-4.60%)

今开:76.37最高:76.58成交:7.13万手 市盈:0.00 上证指数:0.00   0.00%2018-08-17
昨收:75.38 最低:71.65 换手:0.00%振幅:0.00 深证指数:0.00  0.00%15:23:12

集合

竞价

利润表

按照会计年度查询:
报告期2018-03-312017-12-312017-09-302017-03-31
一、营业总收入2,141,764,392.117,765,259,856.285,677,878,889.761,768,190,096.85
营业收入2,141,764,392.117,765,259,856.285,677,878,889.761,768,190,096.85
二、营业总成本1,794,223,129.776,428,779,845.564,503,977,124.971,355,103,966.36
营业成本1,304,294,322.674,516,794,368.383,250,216,204.65996,234,978.2
营业税金及附加10,263,262.4525,722,702.216,452,490.765,037,236.1
销售费用72,992,943.69291,509,533.65209,960,496.1567,709,753.93
管理费用269,043,886.61,269,334,048.92903,431,298.55263,605,228.13
财务费用138,328,963.76184,463,115.24116,364,346.3418,106,156.66
资产减值损失-700,249.4140,956,077.177,552,288.524,410,613.34
三、其他经营收益--11,231,029.2822,895,094.2227,820,237.57
允许价值变动净收益4,144,872.5677,565.75677,565.756,727,671.68
投资净收益-1,267,961.2439,793,811.6339,659,177.635,313,323.13
联营、合营企业投资收益-9,773,631.49------
汇兑净收益--------
四、营业利润365,311,886.861,460,594,895.771,214,238,508.17425,127,125.3
营业外收入3,512,380.66135,975,770.68177,428,241.9626,044,806.81
营业外支出2,831,210.863,950,438.257,490,408.983,453,146.59
非流动资产处置净损失----5,976,724.013,096,055.96
五、利润总额365,993,056.661,592,620,228.21,384,176,341.15447,718,785.52
所得税61,775,065.28295,899,689.78269,276,962.9987,783,875.09
未确认的投资损失--------
六、净利润(百万元)290.661,227.091,063.04336.87
少数股东损益13,560,391.8469,627,059.1251,859,942.3523,065,845.57
归属于母公司股东的净利润290,657,599.541,227,093,479.31,063,039,435.81336,869,064.86
七、每股收益0.311.311.130.36
基本每股收益--1.311.130.36
稀释每股收益--------
TOP↑